Switzerland Telemedicine Market to 2022
DUBLIN, Dec 12, 2018 /PRNewswire/ --
The "Switzerland Telemedicine Market Forecast to 2022 - By Service Platform, by Technology Platform and by Clinical Applications" report has been added to ResearchAndMarkets.com's offering.
This report will help the readers to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report is useful for telemedicine service providers, investors, manufacturers of telemedicine software & hardware, potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.
Switzerland Telemedicine Market
Market Size: Switzerland telemedicine market is marked by the entry of new players including DigitalMedLab, Onlinedoctor.ch, Eedoctors and others. There have been various partnerships in the market which has promoted digital health such as digitalMedLab and Noser Health became partners in 2015. Telemedicine companies are making tie-ups with insurance companies to have an edge over their competitors.
Telemedicine companies launched new apps such as eDiary app for and +WoundDesk app. Switzerland has the most mature market in Europe due to favorable regulatory environment which states that the same laws apply to telemedicine as face-to-face consultation.
Market Segmentation
By Service and Technology Platform
In 2017, services dominated the telemedicine market in terms of revenue. Services generate higher revenue as compared to the technology as the services are recurring in nature and upgrades from time to time. Services include general medical advice, instructions of self-care, advice on serious medical conditions and emergency and office lines for doctors and hospital network. The companies providing these services include Medi24, digitalMedLab, Medgate and SWICA.
By Type of Service Platform
In 2017, Tele home & M-health dominated the service platform in the telemedicine market in Switzerland. The number of consultations that take place every day in case of m-health and tele-home are very high generating higher revenue as compared to the tele-hospitals and clinics.
By Clinical Applications
In 2017, tele-consultation dominated the telemedicine market in Switzerland. The problems for which a patient uses tele-consultation include respiratory issues, digestive issues, eye problem, skin problem, neurology and others. In 2017, tele-dermatology contributed second highest revenue share. The cases of skin cancer in the country are highest in the world.
Tele-pathology contributed third highest share in the telemedicine clinical application. It is used in tele-clinics and tele-hospitals. Tele neurology followed tele-pathology in the telemedicine market as Switzerland is known for having telestroke centers.
Tele Health
Tele health involves the distribution of health-related services and information and allows long distance patient/clinician contact and care, advice, reminders, education, intervention, monitoring and remote admissions. The equipment monitors vital signs such as blood pressure, blood oxygen levels and weight, supporting diagnosis, healthcare management and patient education.
Competitive Landscape
Switzerland Tele Medicine market is moderately concentrated with the presence of around 20-25 telemedicine players in the market. In European countries, Switzerland is the most mature market with its favorable regulatory environment, high number of private insured people and strong telemedicine offerings. Medgate and Medi24 are the leading companies in Switzerland telemedicine market. Other leading companies are SWICA, DigitalMedLab, Eedoctors, OnlineDoctor, DrEd and Swiss Telemedicine Center.
Future Outlook to Switzerland Telemedicine Market
Switzerland Telemedicine market is expected to increase at a double digit CAGR in between the year 2018 and 2022 in terms of revenue due to the increasing number of aging population, growing number of smart phone users and rising healthcare cost. The demand for telemedicine in Switzerland is expected to grow at a rapid pace from 2021 to 2022.
The growth will be driven by the increasing prevalence of chronic diseases and continual investments from both public and private sectors. Artificial intelligence will be the future trend in the Tele-Medicine.
Key Segments Covered
By Type of Service Platform
- Tele Home & M-Health
- Tele-Hospitals & Clinics
By Technology Platform:
- Software
- Hardware
By Clinical Applications
- Tele Consultation
- Tele Dermatology
- Tele Pathology
- Tele Neurology
- Others (Tele radiology, Tele Cardiology, Epidemiology, Prescription Counseling, Surgical Applications, Cardiology and Dentistry)
Key Target Audience
- Telemedicine Services Companies
- Second Medical Opinion Companies
- E-Health Players
- Healthcare IT Companies
- Telemedicine Software Companies
- Telemedicine Hardware Companies
- Consulting service providers
- Private Equity/ VCs/ Investment Banking Companies
Time Period Captured in the Report:
- 2012-2017 - Historical Period
- 2018-2022 - Future Forecast
Companies Covered:
Telemedicine Service Companies:
Medi24, Medgate, SWICA, DigitalMedLab, Eedoctors, DrEd, OnlineDoctor and Swiss Telemedicine Center
Telemedicine Software Companies:
Comacrh Healthcare, Patient Journey App, Connected Health Tech Solutions, Verklizan, Team Scope, AMD Global Telemedicine, Portavita, Blackford Analysis, Cupris Healthcare, Care Zapp and Philips Healthcare
Telemedicine Hardware Companies:
AMD Global Telemedicine, Tele Health Solutions, Global MED, Avizia, Cupris Healthcare, OJBio and InTouch Health
For more information about this report visit https://www.researchandmarkets.com/research/tk3mzk/switzerland?w=5
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article